Table 2.
Results of the multiple ordinal regression and multivariate linear regression analysis about antimicrobial resistant and multi-resistant drugs.
| Dependent variable: resistance profile (ordinal) R2 (Nagelkerke)=0.102; R²=18.402;df=7; p=0.01 independent variables | Estimate (β₀) | Standard error | p |
|---|---|---|---|
| Period of the study (before or during the pandemia) | −0.572 | 0.278 | 0.04 |
| Escherichia coli species | 0.625 | 0.411 | 0.12 |
| Klebsiella pneumoniae species | 0.023 | 0.477 | 0.96 |
| Staphylococcus aureus species | 0.020 | 0.435 | 0.96 |
| Gram profile of bacterias | 0.472 | 0.423 | 0.26 |
| Patient profile | 1.039 | 0.394 | 0.008 |
| Collected fluid site | 0.247 | 0.333 | 0.45 |
| Dependent variable: number of resistant antimicrobial agents per isolate (linear) R2=0.102; F(7,188)=3.064; p=0.004 independent variables | Exp (β) | 95% I.C. | p-value |
| Period of the study (before or during the pandemia) | −2.438 | −4.3 to −0.59 | 0.01 |
| Escherichia coli species | 1.082 | −1.6–3.8 | 0.43 |
| Klebsiella pneumoniae species | 3.593 | 1.2–11.6 | 0.032 |
| Staphylococcus aureus species | 0.998 | 0.98–1.0 | 0.209 |
| Gram profile of bacterias | −0.603 | −3.4−2.2 | 0.67 |
| Patient profile | −4.243 | −6.8 to −1.6 | 0.001 |
| Collected fluid site | −1.016 | −3.2–1.2 | 0.37 |